Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulette A Lyle

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Pharmacogenetics and Genomics|January 13, 2010
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE studyBørge G Nordestgaard, Kimmo Kontula, Marianne Benn, et al.
Journal of Hypertension|March 6, 2009
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension studyMichael Hecht Olsen, Kristian Wachtell, Gareth Beevers, et al.
Blood Pressure|December 17, 2009
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension studySverre E Kjeldsen, Richard B Devereux, Darcy A Hille, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2005
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE studySverre E Kjeldsen, Paulette A Lyle, Jorge R Kizer, et al.
Hypertension (Dallas, Tex. : 1979)|March 26, 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist, Björn Dahlöf, Richard B Devereux, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL studyWilliam F Keane, Zhongxin Zhang, Paulette A Lyle, et al.
Pharmacogenetics and Genomics|January 13, 2010
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE studyBørge G Nordestgaard, Kimmo Kontula, Marianne Benn, et al.
Journal of Hypertension|March 6, 2009
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension studyMichael Hecht Olsen, Kristian Wachtell, Gareth Beevers, et al.
Blood Pressure|December 17, 2009
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension studySverre E Kjeldsen, Richard B Devereux, Darcy A Hille, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2005
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE studySverre E Kjeldsen, Paulette A Lyle, Jorge R Kizer, et al.
Hypertension (Dallas, Tex. : 1979)|March 26, 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist, Björn Dahlöf, Richard B Devereux, et al.
Pageof 3